Evidence map›Paper›PMID 40489076›Full record

ArticleSchizophrenia bulletin2025

Longitudinal Trajectories of Clinical Features in Community Youth With Recurrent Psychosis Spectrum Symptoms: Findings From the Philadelphia Neurodevelopmental Cohort.

Monica E Calkins, Ellyn R Butler, Tyler M Moore, Arielle Ered, Jerome H Taylor, Lauren K White, Ran Barzilay, Kosha Ruparel, Bart Larsen, Sarah S Shahriar and 6 more

Abstract read
In one paragraph

Article in Schizophrenia bulletin, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Monica E CalkinsDepartment of Psychiatry, Neurodevelopment and Psychosis Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.ORCID 0000-0002-0546-0263
Ellyn R ButlerDepartment of Psychology, Northwestern University, Evanston, IL, United States.
Tyler M MooreDepartment of Psychiatry, Neurodevelopment and Psychosis Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Arielle EredDepartment of Psychiatry, Neurodevelopment and Psychosis Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.ORCID 0000-0002-8386-4423
Jerome H TaylorDepartment of Psychiatry, Neurodevelopment and Psychosis Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.ORCID 0000-0003-2787-6232
Lauren K WhiteLifespan Brain Institute of the Children's Hospital of Philadelphia and Penn Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Ran BarzilayDepartment of Psychiatry, Neurodevelopment and Psychosis Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.ORCID 0000-0002-3247-2331
Kosha RuparelDepartment of Psychiatry, Neurodevelopment and Psychosis Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Bart LarsenDepartment of Psychiatry, Neurodevelopment and Psychosis Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Sarah S ShahriarDepartment of Psychiatry, Neurodevelopment and Psychosis Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Tyler E DietterichDepartment of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, CA, United States.
David R RoalfDepartment of Psychiatry, Neurodevelopment and Psychosis Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Daniel H WolfDepartment of Psychiatry, Neurodevelopment and Psychosis Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Theodore D SatterthwaiteDepartment of Psychiatry, Neurodevelopment and Psychosis Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Ruben C GurDepartment of Psychiatry, Neurodevelopment and Psychosis Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Raquel E GurDepartment of Psychiatry, Neurodevelopment and Psychosis Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.

Funding

SCHIZOPHRENIA: A NEUROPSYCHIATRIC PERSPECTIVET32MH019112 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI GUR, RAQUEL E · 1990 to 2024
$6.2M
Evolution of Psychosis in Youth: Multimodal Risk and Resilience MarkersR01MH119219 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI GUR, RAQUEL E, GUR, RUBEN C. · 2019 to 2023
$3.8M
Quantitative Behavioral and Imaging Phenotypes of Amotivation in SchizophreniaR01MH101111 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI WOLF, DANIEL H · 2013 to 2016
$1.6M
Mechanisms of resilience to developmental stress in children and adolescents.K23MH120437 · NIMH · CHILDREN'S HOSP OF PHILADELPHIA · PI BARZILAY, RAN · 2019 to 2022
$775k
A Prospective Study of Endophenotypes in At-Risk Youths and Their SiblingsK08MH079364 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI CALKINS, MONICA E · 2007 to 2011
$750k
Brain iron as a neurodevelopmental mechanism for transdianostic executive dysfunctionK99MH127293 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI LARSEN, BART · 2022 to 2023
$168k
Dowshen Program for NeuroscienceLifespan Brain Institute of CHOP and UPennNIMH NIH HHS K08MH079364NIMH NIH HHS K23MH120437NIMH NIH HHS K99MH127293NIMH NIH HHS L30 MH137813NIMH NIH HHS MH089924NIMH NIH HHS MH089983NIMH NIH HHS R01MH101111NIMH NIH HHS R01 MH119219NIMH NIH HHS R01MH119219NIMH NIH HHS T32 MH019112
6 · The paper itself

Abstract

background and hypothesisIn the general population, more severe, recurrent subthreshold psychosis spectrum (PS) symptoms are associated with a heightened risk of poor outcomes. Here, we expanded and temporally extended our prior 2-year follow-up of community youth with recurrent PS symptoms in the Philadelphia Neurodevelopmental Cohort (PNC) by characterizing longer-term trajectories of symptom domains and global functioning compared to youth with other recurrent psychopathology. STUDY

designThe PNC Time 1 included 9498 community youth (age 8-21) recruited from a pediatric healthcare network. A subsample (n = 752) participated in prospective evaluations (mean visits = 2.75; interval range years first:last visit = 0.2:9.3; mean = 4.52 years; age range years first:last visit = 8.1-21.9:9.5-29.9). Youth were classified based on psychopathology at first and last visits. Longitudinal trajectories of symptom domains (positive, negative, disorganized, general) and global functioning were modeled using generalized additive mixed models. STUDY

resultsYouth with recurrent PS displayed a nonlinear developmental trajectory of positive psychosis symptoms such that severity increased slowly until the early 20s, and then briefly plateaued before increasing significantly in the late 20s. They also exhibited increases over time in disorganized and negative symptoms, and in general symptoms, which were lower in severity and relatively stable in other groups. Global functioning in recurrent PS declined from moderate to serious impairment over time, compared to youth with recurrent other psychopathology, where higher and more stable functioning was observed.

conclusionsResults underscore that PS symptoms in community adolescents reflect dynamic developmental processes into early adulthood, and support evaluating trajectories of multiple symptom and functional domains.

Indexed as

Disease ProgressionPsychotic DisordersSchizophreniaAdolescentChildFemaleFollow-Up StudiesHumansLongitudinal StudiesMalePhiladelphiaRecurrenceYoung Adultdevelopmentdisorganized symptomsglobal role functionglobal social functionnegative symptomsPNCpositive symptomsprospectivepsychosis spectrum

Identifiers

PMID40489076
PMCPMC12236310

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.